NCT02695940View on ClinicalTrials.gov

Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Inverse Psoriasis
Interventions
DRUG

LEO 124249 ointment 30 mg/g

OTHER

LEO 124249 ointment vehicle

Trial Locations (1)

44803

Johannes Niesmann, Bochum

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY